TIDMGSK

RNS Number : 9395F

GlaxoSmithKline PLC

19 November 2020

 
TR-1: Standard form for notification of major holdings 
 
  NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer 
   and to the FCA in Microsoft Word format if possible) 
 
  1a. Identity of the issuer or the                      GlaxoSmithKline PLC 
   underlying issuer of existing shares 
   to which voting rights are attached: 
  1b. Please indicate if the issuer is a non-UK issuer (please mark 
   with an "X" if appropriate) 
  Non-UK issuer 
                                                                                               ------------------ 
  2. Reason for the notification (please mark the appropriate box 
   or boxes with an "X") 
  An acquisition or disposal of voting rights                                                            X 
                                                                                               ------------------ 
  An acquisition or disposal of financial instruments 
                                                                                               ------------------ 
  An event changing the breakdown of voting rights 
                                                                                               ------------------ 
  Other (please specify): 
                                                                                               ------------------ 
  3. Details of person subject to the notification obligation 
  Name                                                   The Capital Group Companies, Inc. 
                                                       ---------------------------------------------------------- 
  City and country of registered                         Los Angeles, USA 
   office (if applicable) 
                                                       ---------------------------------------------------------- 
  4. Full name of shareholder(s) (if different from 3) 
  Name 
                                                       ---------------------------------------------------------- 
  City and country of registered 
   office (if applicable) 
                                                       ---------------------------------------------------------- 
  5. Date on which the threshold                         17/11/2020 
   was crossed or reached: 
                                                       ---------------------------------------------------------- 
  6. Date on which issuer notified                       19/11/2020 
   (DD/MM/YYYY): 
                                                       ---------------------------------------------------------- 
  7. Total positions of person(s) subject to the notification obligation: 
                                     % of voting        % of voting rights    Total of both       Total number 
                                   rights attached      through financial          in %          of voting rights 
                                      to shares            instruments                              of issuer 
                                      (total of           (total of 8.B.1       (8.A + 8.B) 
                                         8.A)                 + 8.B.2) 
                               ----------------------  -------------------  -----------------  ------------------ 
  Resulting situation 
   on the date on 
   which threshold 
   was crossed or 
   reached                       4.95%                   0.00%                4.95%              5,017,424,632 
                               ----------------------  -------------------  -----------------  ------------------ 
  Position of previous 
   notification 
   (if applicable)               5.04%                   0.00%                5.04% 
                               ----------------------  -------------------  -----------------  ------------------ 
 
 
 
  8. Notified details of the resulting situation on the date on which 
   the threshold was crossed or reached: 
  A: Voting rights attached to shares 
  Class/type            Number of voting rights                         % of voting rights 
   of shares 
   ISIN code 
   (if possible) 
                      ----------------------------------------------  --------------------------------- 
                           Direct                 Indirect                  Direct          Indirect 
                          (Art 9 of          (Art 10 of Directive           (Art 9          (Art 10 of 
                          Directive        2004/109/EC) (DTR5.2.1)       of Directive       Directive 
                         2004/109/EC)                                    2004/109/EC)      2004/109/EC) 
                           (DTR5.1)                                        (DTR5.1)         (DTR5.2.1) 
                      ---------------  -----------------------------  ----------------  --------------- 
GB0009252882 
 Common Stock                          200,251,814                                      3.99% 
                      ---------------  -----------------------------  ----------------  --------------- 
US37733W1053 
 Depository 
 Receipt                               48,292,050                                       0.96% 
                      ---------------  -----------------------------  ----------------  --------------- 
 
SUBTOTAL 8.A                           248,543,864                                  4.95% 
                      ----------------------------------------------  --------------------------------- 
 
  B 1: Financial Instruments according to Art. 13(1)(a) of Directive 
   2004/109/EC (DTR5.3.1.1 (a)) 
  Type of financial     Expiration       Exercise/      Number of voting                  % of voting 
   instrument            date             Conversion     rights that may be                rights 
                                          Period         acquired if the instrument 
                                                         is exercised/converted 
                      ---------------  -------------  --------------------------------  --------------- 
  N/A 
                      ---------------  -------------  --------------------------------  --------------- 
                                         SUBTOTAL 
                                          8.B.1 
                                                      --------------------------------  --------------- 
 
  B 2: Financial Instruments with similar economic effect according 
   to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
  Type of financial     Expiration       Exercise/      Physical        Number of         % of voting 
   instrument            date             Conversion     or cash         voting rights     rights 
                                          Period         settlement 
                      ---------------  -------------  --------------  ----------------  --------------- 
  N/A 
                      ---------------  -------------  --------------  ----------------  --------------- 
                                                        SUBTOTAL 
                                                         8.B.2 
                                                                      ----------------  --------------- 
 
 
 
  9. Information in relation to the person subject to the notification 
   obligation (please mark the applicable box with an "X") 
  Person subject to the notification obligation is not controlled 
   by any natural person or legal entity and does not control 
   any other undertaking(s) holding directly or indirectly an 
   interest in the (underlying) issuer. 
  Full chain of controlled undertakings through which the voting                                    X 
   rights and/or the financial instruments are effectively held 
   starting with the ultimate controlling natural person or legal 
   entity (please add additional rows as necessary) 
                                                                                        ------------------------ 
              Name                   % of voting rights         % of voting rights           Total of both 
                                        if it equals             through financial            if it equals 
                                        or is higher              instruments if              or is higher 
                                     than the notifiable           it equals or           than the notifiable 
                                          threshold               is higher than               threshold 
                                                                  the notifiable 
                                                                     threshold 
                                --------------------------  ------------------------  -------------------------- 
 Capital Research and 
  Management Company 
                                --------------------------  ------------------------  -------------------------- 
 Capital Bank and Trust 
  Company 
                                --------------------------  ------------------------  -------------------------- 
 Capital International, 
  Inc. 
                                --------------------------  ------------------------  -------------------------- 
 Capital International 
  Sàrl 
                                --------------------------  ------------------------  -------------------------- 
 Capital International 
  Limited 
                                --------------------------  ------------------------  -------------------------- 
 Total 
                                --------------------------  ------------------------  -------------------------- 
 
 
  10. In case of proxy voting, please identify: 
  Name of the proxy holder 
                                                            ---------------------------------------------------- 
  The number and % of voting rights 
   held 
                                                            ---------------------------------------------------- 
  The date until which the voting 
   rights will be held 
                                                            ---------------------------------------------------- 
 
  11. Additional information: 
  The Capital Group Companies, Inc. ("CGC") is the parent company 
   of Capital Research and Management Company ("CRMC") and Capital 
   Bank & Trust Company ("CB&T"). CRMC is a U.S.-based investment 
   management company that serves as investment manager to the American 
   Funds family of mutual funds, other pooled investment vehicles, 
   as well as individual and institutional clients. CRMC and its 
   investment manager affiliates manage equity assets for various 
   investment companies through three divisions, Capital Research 
   Global Investors, Capital International Investors and Capital 
   World Investors. CRMC is the parent company of Capital Group International, 
   Inc. ("CGII"), which in turn is the parent company of four investment 
   management companies ("CGII management companies"): Capital International, 
   Inc., Capital International Limited, Capital International Sàrl 
   and Capital International K.K. CGII management companies and CB&T 
   primarily serve as investment managers to institutional and high 
   net worth clients. CB&T is a U.S.-based investment management 
   company that is a registered investment adviser and an affiliated 
   federally chartered bank. 
   Neither CGC nor any of its affiliates own shares of the Issuer 
   for its own account. Rather, the shares reported on this Notification 
   are owned by accounts under the discretionary investment management 
   of one or more of the investment management companies described 
   above. 
 
  Place of completion           Los Angeles 
  Date of completion            19/11/2020 
                              ---------------------------------------------------------------------------------- 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLBLBRTMTJBBPM

(END) Dow Jones Newswires

November 19, 2020 12:40 ET (17:40 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Gsk.